GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Integrated Cannabis Solutions Inc (OTCPK:IGPK) » Definitions » Debt-to-EBITDA

Integrated Cannabis Solutions (Integrated Cannabis Solutions) Debt-to-EBITDA : -1.63 (As of Sep. 2022)


View and export this data going back to . Start your Free Trial

What is Integrated Cannabis Solutions Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Integrated Cannabis Solutions's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.65 Mil. Integrated Cannabis Solutions's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.00 Mil. Integrated Cannabis Solutions's annualized EBITDA for the quarter that ended in Sep. 2022 was $-0.40 Mil. Integrated Cannabis Solutions's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was -1.63.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Integrated Cannabis Solutions's Debt-to-EBITDA or its related term are showing as below:

IGPK's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.69
* Ranked among companies with meaningful Debt-to-EBITDA only.

Integrated Cannabis Solutions Debt-to-EBITDA Historical Data

The historical data trend for Integrated Cannabis Solutions's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Cannabis Solutions Debt-to-EBITDA Chart

Integrated Cannabis Solutions Annual Data
Trend Dec20 Dec21
Debt-to-EBITDA
-1.08 -1.69

Integrated Cannabis Solutions Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.64 -2.00 -1.79 -1.75 -1.63

Competitive Comparison of Integrated Cannabis Solutions's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Integrated Cannabis Solutions's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integrated Cannabis Solutions's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Integrated Cannabis Solutions's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Integrated Cannabis Solutions's Debt-to-EBITDA falls into.



Integrated Cannabis Solutions Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Integrated Cannabis Solutions's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.553 + 0) / -0.327
=-1.69

Integrated Cannabis Solutions's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.653 + 0) / -0.4
=-1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.


Integrated Cannabis Solutions  (OTCPK:IGPK) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Integrated Cannabis Solutions Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Integrated Cannabis Solutions's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Integrated Cannabis Solutions (Integrated Cannabis Solutions) Business Description

Traded in Other Exchanges
N/A
Address
1300 N. Florida Mango Road, Site 30, West Palm Beach, FL, USA, 33409
Integrated Cannabis Solutions Inc is a developmental stage company actively engaged in evaluating investment opportunities for early-stage ventures at the crossroads of the rapidly growing fintech and medical/recreational marijuana industries.
Executives
Eugene Caiazzo director, officer: CEO, President 1300 N FLORIDA MANGO RD., STE. 30, WEST PALM BEACH FL 33409